CD19 +
About
Biomarker type: Protein expression
Marker: CD19
Unit: status
Equality: =
Value: Positive
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (4) | CD19 + | Acute Lymphoblastic Leukemia | Blinatumomab | |
| EMA (5) FDA (2) | CD19 +, not BCR::ABL1 | Acute Lymphoblastic Leukemia | Blinatumomab |